scholarly journals Atherosclerotic Renal Artery Stenosis Mimicking Fibromuscular Dysplasia

2011 ◽  
Vol 42 (5) ◽  
pp. 717
Author(s):  
H. Higashi ◽  
S. Inaba ◽  
A. Ogimoto ◽  
T. Okura ◽  
J. Higaki ◽  
...  
Keyword(s):  
Renal Artery ◽  
Renal Artery Stenosis ◽  
Fibromuscular Dysplasia ◽  
Artery Stenosis ◽  
Atherosclerotic Renal Artery Stenosis

scholarly journals Atherosclerotic Renal Artery Stenosis Mimicking Fibromuscular Dysplasia

EJVES Extra ◽  
2011 ◽  
Vol 22 (4) ◽  
pp. e44-e47
Author(s):  
H. Higashi ◽  
S. Inaba ◽  
A. Ogimoto ◽  
T. Okura ◽  
J. Higaki ◽  
...  
Keyword(s):  
Renal Artery ◽  
Renal Artery Stenosis ◽  
Fibromuscular Dysplasia ◽  
Artery Stenosis ◽  
Atherosclerotic Renal Artery Stenosis

Long-Term Outcome After Surgical Kidney Revascularization for Fibromuscular Dysplasia and Atherosclerotic Renal Artery Stenosis

2004 ◽  
Vol 171 (3) ◽  
pp. 1043-1045 ◽  
Author(s):  
ZVONIMIR MAREKOVIĆ ◽  
IVICA MOKOS ◽  
IVAN KRHEN ◽  
NEDJELJKA RIBIČIĆ GORETA ◽  
TOMISLAV RONČEVIČ
Keyword(s):  
Renal Artery ◽  
Renal Artery Stenosis ◽  
Fibromuscular Dysplasia ◽  
Artery Stenosis ◽  
Atherosclerotic Renal Artery Stenosis ◽  
Term Outcome ◽  
Long Term Outcome

Percutaneous Transluminal Dilatation of Renal Artery Stenosis: 2 years' Experience

1981 ◽  
Vol 61 (s7) ◽  
pp. 481s-483s ◽  
Author(s):  
U. Kuhlmann ◽  
W. Vetter ◽  
A. Grüntzig ◽  
E. Schneider ◽  
G. Pouliadis ◽  
...  
Keyword(s):  
Renal Artery ◽  
Renal Artery Stenosis ◽  
Renovascular Hypertension ◽  
Fibromuscular Dysplasia ◽  
Artery Stenosis ◽  
Atherosclerotic Renal Artery Stenosis ◽  
Atherosclerotic Stenosis ◽  
Percutaneous Transluminal ◽  
Percutaneous Transluminal Dilatation

1. Percutaneous transluminal dilatation was performed in 37 patients with renovascular hypertension: 24 had atherosclerotic renal artery stenosis and 13 had fibromuscular dysplasia. 2. Percutaneous transluminal dilatation could not be performed for technical reasons in three (8%) of the 37 patients. 3. In the remaining 34 patients blood pressure fell significantly (P < 0.001) from 201 ± 31/118 ± 14 mmHg to 144 ± 22/91 ± 11 mmHg 3 days after the procedure. The respective values at months 6 and 24 were 148 ± 26/89 ± 12 mmHg (n = 23, P < 0.001) and 143 ± 14/89 ± 6 mmHg (n = 8, P < 0.001). 4. Certain differences between the two subgroups emerged in the response to percutaneous transluminal dilatation (6 months values, n = 23): cure rate was higher in patients with fibromuscular dysplasia than in those with atherosclerotic stenosis (67% vs 35%) and in contrast to atherosclerotic stenosis none of the cases with fibromuscular dysplasia was unimproved. 5. Follow-up angiography performed at month 6 showed recurrence of slight renal artery stenosis in five out of 19 patients (all atherosclerotic). 6. Complications were seen in six (16%) of the 37 patients. 7. Our results show that percutaneous transluminal dilatation is a valid method for the treatment of renovascular hypertension. Patients with fibromuscular dysplasia may show a better response than those with atherosclerotic stenosis. In this study the latter was complicated by a high risk of developing restenosis. Finally a complication rate of 16% requires careful selection of patients.

scholarly journals Pathophysiological differences between multifocal fibromuscular dysplasia and atherosclerotic renal artery stenosis

2017 ◽  
Vol 35 (4) ◽  
pp. 845-852 ◽  
Author(s):  
Daan J.L. van Twist ◽  
Alfons J.H.M. Houben ◽  
Michiel W. de Haan ◽  
Peter W. de Leeuw ◽  
Abraham A. Kroon
Keyword(s):  
Renal Artery ◽  
Renal Artery Stenosis ◽  
Fibromuscular Dysplasia ◽  
Artery Stenosis ◽  
Atherosclerotic Renal Artery Stenosis

scholarly journals Clinical response scores to predict blood pressure and renal function improvement following renal artery stenting for atherosclerotic renal artery stenosis

2020 ◽  
Vol 41 (Supplement_2) ◽  
Author(s):  
A Kablak-Ziembicka ◽  
A Roslawiecka ◽  
R Badacz ◽  
A Sokolowski ◽  
P Musialek ◽  
...  
Keyword(s):  
Blood Pressure ◽  
Logistic Regression ◽  
Renal Function ◽  
Renal Artery ◽  
Renal Artery Stenosis ◽  
Predictive Models ◽  
Artery Stenosis ◽  
Atherosclerotic Renal Artery Stenosis ◽  
Baseline Serum ◽  
Kidney Length

Abstract Background It is little known about predictors of systolic (SBP) and diastolic (DBP) blood pressure or renal function (eGFR) improvement in patients with atherosclerotic renal artery stenosis (ARAS) undergoing stent-assisted angioplasty (PTA). Therefore, we aimed to build a prediction scores that would indicate characteristics of patient subsets with ARAS most likely to have clinical improvement following PTA. Methods 201 patients who underwent PTA for ARAS (2003–2018) were categorized as eGFR or SBP/DBP responders based on eGFR increase of ≥11 ml/min/1.73m2, decrease of SBP ≥20mmHg and DBP ≥5mmHg at 12-months following PTA. The remaining patients were classified as non-responders. The performance of logistic regression models were evaluated by basic decision characteristics. Continuous data have been transformed into binary coding with help of operating characteristic (ROC) curve. Predictive models have been constructed for each followed by construction of predictive models in each of 3 categories. Results Logistic regression analysis showed that: baseline SBP>145 mmHg, DBP >82 mmHg, previous myocardial infarction and Renal-Aotric-Ratio >5.1 were independent influencing factors of SBP response, with relative risk percentage shares of 69.8%; 12.1%; 10.9%; and 7.2%, respectively (sensitivity: 82%, specificity: 86.3%, positive (PPV):82% and negative (NPV) predictive values: 86.3%). The DBP decrease prediction model included baseline SBP >145 mmHg and DBP >82 mmHg, the ARAS progression, index kidney length >106 mm, and bilateral PTA with respective shares of 35.0%; 21.8%; 18.2%; 13.3% and 11.8%. (sensitivity: 76%, specificity: 77.8%, PPV: 80.7% and NPV: 72.6%). The eGFR increase was associated with baseline serum creatinine >122 μmol/L but eGFR greater than 30 ml/min/1.73m2, index kidney length >98 mm, end-diastolic velocity in index renal artery, renal resistive index <0.74, and requirement for >3 BP medications, with respective shares of 24.4%; 24.4%; 21.2%; 15% and 15% (sensitivity: 33.3%, specificity: 93.5%, PPV: 65.6% and NPV: 78.9%). Conclusions Current study identified clinical characteristics of patients who most likely to respond to PTA for ARAS. The sutability of the score should be verified in a prospective cohort of patients referred to PTA of ARAS Funding Acknowledgement Type of funding source: None

Follow-up of primary Palmaz-Schatz stent placement for atherosclerotic renal artery stenosis

1995 ◽  
Vol 75 (15) ◽  
pp. 1051-1055 ◽  
Author(s):  
Gerald Dorros ◽  
Michael Jaff ◽  
Aditiya Jain ◽  
Christine Dufek ◽  
Lynne Mathiak
Keyword(s):  
Renal Artery ◽  
Renal Artery Stenosis ◽  
Stent Placement ◽  
Artery Stenosis ◽  
Atherosclerotic Renal Artery Stenosis
Sign in / Sign up

Export Citation Format

Share Document